Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre de la Taille

Showing results (231-240 of 389) with videos related to

Pageof 39
Sort By:
European Urology|October 7, 2015
Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot StudyRené Yiou, Leila Hamidou, Brigitte Birebent, et al.
World Journal of Urology|February 1, 2018
Prostatic injection of botulinum toxin is not inferior to optimized medical therapy in the management of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a randomized clinical trialGrégoire Robert, Aurélien Descazeaud, Gilles Karsenty, et al.
European Urology|December 16, 2010
Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillanceGuillaume Ploussard, Xavier Durand, Evanguelos Xylinas, et al.
World Journal of Urology|February 13, 2021
Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic reviewGaëtan Devos, Bram Vansevenant, Gert De Meerleer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 23, 2018
Reappraisal of HER2 status in the spectrum of advanced urothelial carcinoma: a need of guidelines for treatment eligibilityAnissa Moktefi, Damien Pouessel, Jing Liu, et al.
BJU International|January 7, 2012
The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomyXavier Durand, Evanguelos Xylinas, Camelia Radulescu, et al.
European Urology|July 13, 2010
External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcomeMarco Auprich, Alexander Haese, Jochen Walz, et al.
Histopathology|June 13, 2012
SMARCB1/INI1 inactivation in renal medullary carcinomaJulien Calderaro, Julien Moroch, Gaelle Pierron, et al.
Urologia Internationalis|March 27, 2010
Impact of lower urinary tract symptoms on discomfort in men aged between 50 and 80 yearsGrégoire Robert, Aurélien Descazeaud, Rahmene Azzouzi, et al.
The Journal of Urology|May 13, 2015
Management of Node Only Recurrence after Primary Local Treatment for Prostate Cancer: A Systematic Review of the LiteratureGuillaume Ploussard, Christophe Almeras, Alberto Briganti, et al.
Pageof 39

Showing results (231-240 of 389) with videos related to

Sort By:
Pageof 39
European Urology|October 7, 2015
Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot StudyRené Yiou, Leila Hamidou, Brigitte Birebent, et al.
World Journal of Urology|February 1, 2018
Prostatic injection of botulinum toxin is not inferior to optimized medical therapy in the management of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a randomized clinical trialGrégoire Robert, Aurélien Descazeaud, Gilles Karsenty, et al.
European Urology|December 16, 2010
Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillanceGuillaume Ploussard, Xavier Durand, Evanguelos Xylinas, et al.
World Journal of Urology|February 13, 2021
Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic reviewGaëtan Devos, Bram Vansevenant, Gert De Meerleer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 23, 2018
Reappraisal of HER2 status in the spectrum of advanced urothelial carcinoma: a need of guidelines for treatment eligibilityAnissa Moktefi, Damien Pouessel, Jing Liu, et al.
BJU International|January 7, 2012
The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomyXavier Durand, Evanguelos Xylinas, Camelia Radulescu, et al.
European Urology|July 13, 2010
External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcomeMarco Auprich, Alexander Haese, Jochen Walz, et al.
Histopathology|June 13, 2012
SMARCB1/INI1 inactivation in renal medullary carcinomaJulien Calderaro, Julien Moroch, Gaelle Pierron, et al.
Urologia Internationalis|March 27, 2010
Impact of lower urinary tract symptoms on discomfort in men aged between 50 and 80 yearsGrégoire Robert, Aurélien Descazeaud, Rahmene Azzouzi, et al.
The Journal of Urology|May 13, 2015
Management of Node Only Recurrence after Primary Local Treatment for Prostate Cancer: A Systematic Review of the LiteratureGuillaume Ploussard, Christophe Almeras, Alberto Briganti, et al.
Pageof 39